Crinetics - Rasio total nilai perusahaan marang pendapatan CRNX

Logo perusahaan publik Crinetics (CRNX)

Geopolitical tensions and sanctions are complicating reagent logistics and global drug trials. The EV/Sales ratio demonstrates stable positioning, with the metric currently standing at 186224.38. The high level of scientific expertise within the leadership of Crinetics Pharmaceuticals (CRNX) ensures transparent progress in Phase 3 trials. The current lack of profit due to zero sales is offset by a significant volume of accumulated capital from previous investments.

CRNX Crinetics Pharmaceuticals: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 12.09.2026

CRNX (Crinetics Pharma): rincian analitis lan laporan miturut indikator

Pambiji fundamental perusahaan:CRNX (crinetics.com)
Produk asil prodhuksi Crinetics Pharmaceuticals, Inc.

This indicator compares the total enterprise value, including net debt, with the volume of generated revenue, allowing for the determination of the asset's real market value regardless of the capital structure. An analysis of the enterprise value-to-sales multiple helps assess the financial stability of Crinetics Pharmaceuticals (CRNX), confirming how effectively the management's scientific expertise and the success of phase III trials are converted into the company's market capitalization.

Analisis pesaing

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Rasio nilai perusahaan marang pendapatan NewAmsterdam Pharma N.V. NAMS|Rasio total nilai perusahaan marang pendapatan Soleno Therapeutics Inc (SLNO)|FOLD - Rasio nilai perusahaan marang pendapatan|ETNB: Rasio nilai perusahaan marang pendapatan|AGIO: Multiplikator EV/Sales|Structure Therapeutics Inc. - Nilai bisnis marang pendapatan|MDXG (MiMedx Corp) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Rezolute Inc RZLT|Multiplikator EV/Sales LXRX|Rasio total nilai perusahaan marang pendapatan MBX Corp|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)